The efficacy of Endoscopic Sleeve Gastroplasty, include its ability to promote weight loss, improve metabolic health, and enhance quality of life. Endoscopic Sleeve Gastroplasty (ESG) is a relatively new weight loss procedure that has gained a lot of popularity in recent years. This minimally invasive procedure involves the use of an endoscope, a flexible tube with a camera attached to it, to reduce the size of the stomach and restrict the amount of food a person can consume.
In this blog post, we will also explore the benefits and risks of ESG as an obesity management technique.
ESG is a viable option for individuals who are obese or overweight and are unable to lose weight through diet and exercise alone. The procedure involves reducing the size of the stomach by suturing it from the inside, thereby creating a tube-like structure that restricts the amount of food a person can consume.
The procedure is performed under sedation and takes around 1-2 hours to complete.
ESG is an effective weight loss procedure, with patients typically losing between 15-20% of their excess weight in the first year after the procedure. This weight loss can lead to significant improvements in health, including a reduction in blood pressure, cholesterol levels, and the risk of developing diabetes.
ESG is a minimally invasive procedure, meaning that it does not require major surgery or incisions. This reduces the risk of complications, minimizes scarring, and reduces the recovery time compared to traditional weight loss surgeries like gastric bypass.
Recovery time after ESG is relatively quick, with most patients able to return to work and normal activities within a few days of the procedure. This is because the procedure is minimally invasive and does not involve major surgery or incisions.
ESG can improve the quality of life of obese individuals by reducing the risk of developing weight-related health problems, improving self-esteem, and increasing mobility and physical activity levels.
Like any medical procedure, ESG carries the risk of complications. These can include bleeding, perforation of the stomach, or damage to surrounding organs. However, the risk of these complications is relatively low, and they can usually be managed with prompt medical attention.
ESG can cause side effects such as nausea, vomiting, and abdominal pain. These side effects are usually temporary and resolve within a few days of the procedure.
While ESG is an effective weight loss procedure, there is a risk of weight regain if the patient does not adhere to a healthy diet and exercise regimen after the procedure.
Endoscopic Sleeve Gastroplasty (ESG) is a minimally invasive weight loss procedure that involves using an endoscope to reduce the size of the stomach. It is an attractive option for people who want to lose weight but do not want to undergo surgery. Here are some key aspects of ESG’s efficacy:
Studies have shown that ESG can lead to significant weight loss in obese individuals. A meta-analysis of 15 studies found that patients who underwent ESG lost an average of 15.5 kg (34.17 pounds) over a follow-up period of 12 months.
Another study found that ESG led to an average weight loss of 18.5 kg (40.78 pounds) after 18 months of follow-up. The weight loss achieved with ESG is comparable to that of other bariatric procedures such as a gastric sleeve or Roux-en-Y gastric bypass.
Obesity is associated with several comorbidities such as type 2 diabetes, high blood pressure, and sleep apnea. ESG has been shown to improve these comorbidities in obese individuals. A study found that after 12 months of follow-up, ESG significantly reduced hemoglobin A1c levels (a marker of blood sugar control) in patients with type 2 diabetes.
Another study found that ESG led to a significant reduction in blood pressure in patients with hypertension. Additionally, ESG has been shown to improve obstructive sleep apnea and quality of life in obese individuals.
ESG is a relatively new weight loss procedure, and studies comparing efficacy of endoscopic sleeve gastroplasty with other weight loss procedures are limited. However, available studies suggest ESG is as effective as other bariatric procedures such as gastric sleeve and Roux-en-Y gastric bypass in weight loss.
A study comparing efficacy of Endoscopic Sleeve Gastroplasty with gastric sleeve found that ESG led to similar weight loss as gastric sleeve at 12 months of follow-up.
Another study found that ESG was associated with lower complication rates and shorter hospital stays compared to gastric bypass.
ESG is a safe and effective weight loss procedure that can help obese individuals achieve their weight loss goals and improve their overall health. While the procedure carries some risks, these are minor and can be managed with prompt medical attention.
If you are considering Endoscopic Sleeve Gastroplasty in Dallas, TX, as a weight loss option, it is important to speak with a qualified healthcare professional to determine if you are a good candidate for the procedure.